Vimarsana
Biggest News Aggregation in the World

Timothy Biba News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Timothy Biba. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Timothy Biba Today - Breaking & Trending Today

Galera Schedules Type A Meeting with FDA to Discuss Next Steps for Avasopasem - Vimarsana News

Galera Schedules Type A Meeting with FDA to Discuss Next Steps for Avasopasem

Published: September 18, 2023

MALVERN, Pa., Sept. 18, 2023 -- Galera Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that...

Source: marketscreener.com
Related Topics:
United StatesTimothy BibaMel SorensenChristopher DegnanWilliam WindhamExchange CommissionCompany New Drug ApplicationSolebury Strategic CommunicationsDrug AdministrationGalera Therapeutics IncComplete Response LetterNew Drug ApplicationFast TrackBreakthrough TherapyOrphan Drug DesignationPrivate Securities Litigation Reform ActBreakthrough Therapy DesignationFast Track DesignationAnnual Report
Galera Reports Second Quarter 2023 Financial Results and Recent Corporate Updates - Vimarsana News

Galera Reports Second Quarter 2023 Financial Results and Recent Corporate Updates

Published: August 14, 2023

Company received Complete Response Letter from FDA for avasopasem and intends to request Type A meeting with FDA to discuss potential next steps Cash runway extended into Q2 2024 in connection with... -Today at 07:02 am- MarketScreener

Source: marketscreener.com
Related Topics:
United StatesWilliam WindhamChristopher DegnanMel SorensenTimothy BibaGalera Therapeutics IncAmerican Society Of Clinical OncologySolebury Strategic CommunicationsDrug AdministrationExchange CommissionComplete Response LetterInduced Severe Oral MucositisNew Drug ApplicationNeck CancerAmerican SocietyClinical OncologyAnnual MeetingGlomerular Filtration RateAdvanced Pancreatic CancerOrphan Drug DesignationSmall Cell Lung CancerFast TrackBreakthrough TherapyPrivate Securities Litigation Reform ActBreakthrough Therapy Designation